SCHEMBL7702104

SCHEMBL7702104

FC(F)(F)c1c[c]cc(C(F)(F)F)c1-c1ccsc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 6/20 0.38
CYP2B6 P20813 3/20 0.38
CYP2E1 P05181 2/20 0.38
ENPP1 P22413 1/20 0.34
KCNH2 Q12809 1/20 0.32
PDK2 Q15119 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
TOP1 P11387 1/20 0.31
CCNE2 O96020 1/20 0.31
CDK4 P11802 1/20 0.31
CCND1 P24385 1/20 0.31
CCNE1 P24864 1/20 0.31
CDK2 P24941 1/20 0.31
PTGS2 P35354 1/20 0.31
SLC5A2 P31639 1/20 0.31
IDO1 P14902 1/20 0.31
NQO2 P16083 1/20 0.30
PRMT6 Q96LA8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7465724 0.74 KIF11 (0.41) ENPP1
SCHEMBL7704882 0.72 KDM4E (0.37) ENPP1PTGS2IDO1
SCHEMBL7701995 0.71 CYP11B1 (0.37) CYP2A6
SCHEMBL7702032 0.71 AR (0.46) ENPP1
SCHEMBL7702101 0.70 TOP1 (0.35) CYP2A6CYP2B6CYP2E1ENPP1KCNH2
SCHEMBL5924659 0.69 CYP2A6 (0.56) CYP2A6CYP2B6CYP2E1KCNH2CYP3A4
SCHEMBL7704658 0.68 ERN1 (0.40) KCNH2CCNE2CCNE1CDK2
SCHEMBL11287918 0.67 MAP4K4 (0.45) CYP3A4CYP2C9CYP2C19IDO1
SCHEMBL7699908 0.67 AHR (0.45)
SCHEMBL27810932 0.67 MPL (0.50) CYP2A6CYP2B6CYP2E1KCNH2PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242399-A1 $g(a)-ARYLETHYLPIPERAZINE DERIVATIVES AS NEUROKININ ANTAGONISTS UCB S.A. (BE) 2002-09-25 EP disclosed
WO-2001046167-A1 α-ARYLETHYLPIPERAZINE DERIVATIVES AS NEUROKININ ANTAGONISTS UCB, S.A. (BE) 2001-06-28 WO disclosed